The in vitro and in vivo data presented here demonstrate that xanthohumol can target the Ets-1/c-Met signaling pathway to inhibit the growth of osimertinib-resistant NSCLC cells by interfering with the binding of USP9X to Ets-1. The gene discussed is MET; the disease is non-small cell lung carcinoma.